References
- World Health Orgnaizaiton. WHO coronavirus (COVID-19) dashboard. World Health Orgnaizaiton; 2023 [ updated August 2, 2023]. Available from: https://covid19.who.int/. Accessed August 2, 2023.
- World Health Orgnaizaiton. WHO coronavirus (COVID-19) dashboard. World Health Orgnaizaiton; 2023 [ updated August 2, 2023]. Available from: https://covid19.who.int/region/wpro/country/au. Accessed August 2, 2023.
- Australian Bureau of Statistics. National, state and territory population. Australian Bureau of Statistics; 2022 [ updated March 16, 2023]. Available from: https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/sep-2022. Accessed March 16, 2023.
- NSW Health. COVID-19 in NSW. NSW Government; 2023 [ updated March 17, 2023]. Available from: https://www.health.nsw.gov.au/Infectious/covid-19/Pages/stats-nsw.aspx. Accessed March 16, 2023.
- Australian Bureau of Statistics. Effects of COVID-19 strains on the Australian economy. Australian Bureau of Statistics; 2022.
- Department of Health and Aged Care. Weekly COVID-19 reporting|Australian Government Department of Health and Aged Care. Department of Health and Aged Care; 2023.
- World Health Organization. Coronavirus disease (COVID-19); 2023. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed August 5, 2023.
- Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
- Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
- Bedolla-Barajas M, Morales-Romero J, Bedolla-Pulido TR, et al. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic. Allergol Immunopathol. 2021;49(3):1–7. doi:10.15586/aei.v49i3.7
- Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi:10.15585/mmwr.mm6915e3
- Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985
- Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
- Dolby T, Nafilyan V, Morgan A, Kallis C, Sheikh A, Quint JK. Relationship between asthma and severe COVID-19: a national cohort study. Thorax. 2023;78(2):120–127. doi:10.1136/thoraxjnl-2021-218629
- Sousa BLA, Brentani A, Costa Ribeiro CC, et al. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study. BMJ Open. 2021;11(9):e050724. doi:10.1136/bmjopen-2021-050724
- Beken B, Ozturk GK, Aygun FD, Aydogmus C, Akar HH. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(5):569–575. doi:10.1016/j.anai.2021.01.018
- Yuan Y, Wang QP, Sun D, et al. Differences in Immune Responses between Children and Adults with COVID-19. Curr Med Sci. 2021;41(1):58–61. doi:10.1007/s11596-021-2318-1
- Sydney Children’s Hospitals Network. Sydney Children’s Hospitals Network, 2021 Annual Review. Sydney: Sydney Children’s Hospitals Network; 2021.
- Independent Health and Aged Care Pricing Authority. How to classify COVID-19 – guidance for data analysts using ICD-10-AM Eleventh Edition. Independent Health and Aged Care Pricing Authority; 2022. Available from: https://www.ihacpa.gov.au/sites/default/files/2022-12/How%20to%20classify%20COVID-19%20%E2%80%93%20Guidance%20for%20data%20analysts%20using%20ICD-10-AM%20Eleventh%20Edition.PDF. Accessed August 8, 2023.
- Australian Bureau of Statistics. Socio-economic indexes for areas. Australian Bureau of Statistics; 2023 [ updated May 6, 2022]. Available from: https://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa. Accessed March 16, 2023.
- Kalyanaraman Marcello R, Dolle J, Grami S, et al. Characteristics and outcomes of COVID-19 patients in New York City’s public hospital system. PLoS One. 2020;15(12):e0243027. doi:10.1371/journal.pone.0243027
- Rao S, Hurst JH, Zhao C, et al. Asthma and the risk of SARS-CoV-2 infection among children and adolescents. Pediatrics. 2022;149(6). doi:10.1542/peds.2021-056164
- Floyd GC, Dudley JW, Xiao R, et al. Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19. J Allergy Clin Immunol Pract. 2021;9(5):2077–2079.e2072. doi:10.1016/j.jaip.2021.02.038
- Ellis RJ, Moffatt CR, Aaron LT, et al. Factors associated with hospitalisations and deaths of residential aged care residents with COVID-19 during the Omicron (BA.1) wave in Queensland. Med J Aust. 2023;218(4):174–179. doi:10.5694/mja2.51813
- Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75(11):2829–2845. doi:10.1111/all.14429
- Wark PAB, Pathinayake PS, Kaiko G, et al. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology. 2021;26(5):442–451. doi:10.1111/resp.14003
- Morrison CB, Edwards CE, Shaffer KM, et al. SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Proc Natl Acad Sci U S A. 2022;119(16):e2119680119. doi:10.1073/pnas.2119680119
- Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281–292.e286. doi:10.1016/j.cell.2020.02.058
- Wang JY, Pawankar R, Tsai HJ, Wu LS, Kuo WS. COVID-19 and asthma, the good or the bad? Allergy. 2021;76(2):565–567. doi:10.1111/all.14480
- Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T. The delta and omicron variants of SARS-CoV-2: what we know so far. Vaccines. 2022;10(11):1926. doi:10.3390/vaccines10111926
- Lim S, Zhang M, Chang TL. ACE2-independent alternative receptors for SARS-CoV-2. Viruses. 2022;14(11):2535. doi:10.3390/v14112535
- Gaietto K, Snyder O, Bergum N, et al. Differences in COVID-19-triggered pediatric asthma exacerbations across variant waves. Eur Respir J. 2022;60(suppl 66):1353.
- Kudlaty E, Guo A, Patel G, Watts M, Peters A. Rates of corticosteroid and antibiotic prescriptions are significantly increased with omicron as compared to alpha and delta variants of COVID-19 in patients with asthma. J Allergy Clin Immunol. 2023;151(2):AB331. doi:10.1016/j.jaci.2022.12.766
- Wikipedia. COVID-19 pandemic in New South Wales. WikiMedia Foundation; 2023 [ updated March 8, 2023]. Available from: https://en.wikipedia.org/wiki/COVID-19_pandemic_in_New_South_Wales. Accessed March 16, 2023.
- Walker L. Australia has opened its borders to unvaccinated travellers. Here’s what you need to know. ABC: ABC News Website; 2022. Available from: https://www.abc.net.au/news/2022-07-06/australia-opens-borders-to-unvaccinated-travellers/101212102. Accessed March 16, 2023.
- Homaira N, Hu N, Owens L, et al. Impact of lockdowns on paediatric asthma hospital presentations over three waves of COVID-19 pandemic. Allergy Asthma Clin Immunol. 2022;18(1):53. doi:10.1186/s13223-022-00691-1
- Iezadi S, Gholipour K, Azami-Aghdash S, et al. Effectiveness of non-pharmaceutical public health interventions against COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(11):e0260371. doi:10.1371/journal.pone.0260371
- Australian Bureau of Statistics. COVID-19 Mortality in Australia: deaths registered until 31 January 2023. Australian Bureau of Statistics; 2023. Available from: https://www.abs.gov.au/articles/covid-19-mortality-australia-deaths-registered-until-31-january-2023. Accessed March 16, 2023.
- Flaxman S, Whittaker C, Semenova E, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Netw Open. 2023;6(1):e2253590. doi:10.1001/jamanetworkopen.2022.53590
- Wang Y, Chen J, Chen W, et al. Does asthma increase the mortality of patients with COVID-19? A systematic review and meta-analysis. Int Arch Allergy Immunol. 2021;182(1):76–82. doi:10.1159/000510953
- Poddighe D, Kovzel E. Impact of anti-type 2 inflammation biologic therapy on COVID-19 clinical course and outcome. J Inflamm Res. 2021;14:6845–6853. doi:10.2147/JIR.S345665
- Ren J, Pang W, Luo Y, et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J Allergy Clin Immunol Pract. 2022;10(1):124–133. doi:10.1016/j.jaip.2021.10.049
- Dupont A, Couffignal C, Arias C, et al. Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients. Respir Res. 2022;23(1):342. doi:10.1186/s12931-022-02265-6
- Green I, Merzon E, Vinker S, Golan-Cohen A, Magen E. COVID-19 susceptibility in bronchial asthma. J Allergy Clin Immunol Pract. 2021;9(2):684–692.e681. doi:10.1016/j.jaip.2020.11.020
- Global Initiative for Asthma. Pocket guide for asthma management and prevention (for adults and children older than 5 years). Global Initiative for Asthma; 2020 [ updated 2020]. Available from: https://ginasthma.org/wp-content/uploads/2020/04/Main-pocket-guide_2020_04_03-final-wms.pdf. Accessed August 8, 2023.
- Zein JG, Mitri J, Bell JM, Lopez D, Strauss R, Attaway AH. The relationship of asthma severity to COVID-19 outcomes. J Allergy Clin Immunol Pract. 2022;10(1):318–321 e312. doi:10.1016/j.jaip.2021.10.041
- Selberg S, Karlsson Sundbaum J, Konradsen JR, et al. Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19. Respir Med. 2023;216:107308. doi:10.1016/j.rmed.2023.107308
- Lin DY, Gu Y, Xu Y, et al. Effects of vaccination and previous infection on omicron infections in children. N Engl J Med. 2022;387(12):1141–1143. doi:10.1056/NEJMc2209371